Please enable JavaScript to continue using this application.

Compare $ACAD vs $IDYA | Chartloom

Compare

$ACAD vs $IDYA

ACADIA Pharmaceuticals Inc · IDEAYA Biosciences Inc

ACAD

ACADIA Pharmaceuticals Inc

IDYA

IDEAYA Biosciences Inc

Compare $ACAD vs $IDYA

Comparing ACADIA Pharmaceuticals Inc and IDEAYA Biosciences Inc

ACADACADIA Pharmaceuticals Inc

IDYAIDEAYA Biosciences Inc

ACADACADIA Pharmaceuticals Inc

Market cap

$3.39B

P/E (TTM)

8.99x

Forward P/E (NTM)

23.42x

Forward P/S (NTM)

2.37x

Rev growth (TTM)

48.3%

YTD performance

-24.8%

52W performance

-7.2%

FCF yield

4.3%

IDYAIDEAYA Biosciences Inc

Market cap

$3.43B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

59.38x

Rev growth (TTM)

3244.7%

YTD performance

6.7%

52W performance

34.5%

FCF yield

-3.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACAD

IDYA

Detailed metrics comparison

ACAD

ACADIA Pharmaceuticals Inc

IDYA

IDEAYA Biosciences Inc

Market Cap

ACAD$3.39B

IDYA$3.43B

Enterprise Value

ACAD$3.00B

IDYA$3.16B

Price

ACAD$19.78

IDYA$36.11

P/E Ratio

ACAD8.99x

IDYAN/A

P/S Ratio

ACAD2.97x

IDYA14.66x

EV/Sales

ACAD2.64x

IDYA13.50x

EV/EBITDA

ACAD24.70x

IDYA0.00x

P/B Ratio

ACAD2.63x

IDYA3.01x

P/FCF Ratio

ACAD23.26x

IDYAN/A

EV/FCF

ACAD20.62x

IDYA-27.76x

PEG Ratio

ACAD0.13x

IDYAN/A

Forward P/E (NTM)

ACAD23.42x

IDYAN/A

Forward P/S (NTM)

ACAD2.37x

IDYA59.38x

Revenue (TTM)

ACAD$1.14B

IDYA$234M

Revenue Growth (YoY)

ACAD48.3%

IDYA3244.7%

Forward Rev Growth

ACAD12.6%

IDYA218.2%

Gross Margin (TTM)

ACAD91.1%

IDYA0.0%

Operating Margin (TTM)

ACAD7.6%

IDYA0.0%

EBITDA Margin (TTM)

ACAD8.6%

IDYA-91.5%

Net Margin (TTM)

ACAD33.4%

IDYA-74.8%

FCF Margin (TTM)

ACAD12.8%

IDYA-48.6%

Net Income (TTM)

ACAD$380M

IDYA$-175M

FCF (TTM)

ACAD$146M

IDYA$-114M

EPS (TTM)

ACAD$2.20

IDYA-$1.90

ROE (TTM)

ACAD32.4%

IDYA-1647.0%

ROA (TTM)

ACAD24.4%

IDYA-1511.0%

ROIC (TTM)

ACAD32.4%

IDYA-1647.0%

Cash

ACAD$385M

IDYA$273M

Debt

ACAD$0

IDYA$0

Net Cash/Debt

ACAD$385M

IDYA$273M

Current Ratio (TTM)

ACAD3.39x

IDYA10.45x

Quick Ratio (TTM)

ACAD3.11x

IDYA10.21x

Debt/Equity (TTM)

ACAD0.00x

IDYA0.00x

Debt/Assets (TTM)

ACAD0.0%

IDYA0.0%

Interest Coverage (TTM)

ACADN/A

IDYAN/A

Net Debt/EBITDA (TTM)

ACAD0.00x

IDYA0.00x

Beta

ACAD0.91

IDYA0.04

52W Performance

ACAD-7.2%

IDYA34.5%

YTD Performance

ACAD-24.8%

IDYA6.7%

% from 52W High

ACAD-36.1%

IDYA-15.4%

% from 52W Low

ACAD2.4%

IDYA38.6%

Asset Turnover (TTM)

ACAD0.73x

IDYA0.20x

FCF Yield (TTM)

ACAD4.3%

IDYA-3.3%

Earnings Yield (TTM)

ACAD11.2%

IDYA-5.1%

Dividend Yield (TTM)

ACADN/A

IDYAN/A

Rule of 40

ACAD61.1

IDYA3,196.0

EV/GP/RG

ACAD0.09

IDYAN/A

Ticker research

View ACAD research View IDYA research

Metric	ACAD ACADIA Pharmaceuticals Inc	IDYA IDEAYA Biosciences Inc
Market & Valuation
Market Cap	$3.39B	$3.43B
Enterprise Value	$3.00B	$3.16B
Price	$19.78	$36.11
P/E Ratio	8.99x	N/A
P/S Ratio	2.97x	14.66x
EV/Sales	2.64x	13.50x
EV/EBITDA	24.70x	0.00x
P/B Ratio	2.63x	3.01x
P/FCF Ratio	23.26x	N/A
EV/FCF	20.62x	-27.76x
PEG Ratio	0.13x	N/A
Forward P/E (NTM)	23.42x	N/A
Forward P/S (NTM)	2.37x	59.38x
Revenue & Growth
Revenue (TTM)	$1.14B	$234M
Revenue Growth (YoY)	48.3%	3244.7%
Forward Rev Growth	12.6%	218.2%
Profitability
Gross Margin (TTM)	91.1%	0.0%
Operating Margin (TTM)	7.6%	0.0%
EBITDA Margin (TTM)	8.6%	-91.5%
Net Margin (TTM)	33.4%	-74.8%
FCF Margin (TTM)	12.8%	-48.6%
Net Income (TTM)	$380M	$-175M
FCF (TTM)	$146M	$-114M
EPS (TTM)	$2.20	-$1.90
ROE (TTM)	32.4%	-1647.0%
ROA (TTM)	24.4%	-1511.0%
ROIC (TTM)	32.4%	-1647.0%
Financial Health
Cash	$385M	$273M
Debt	$0	$0
Net Cash/Debt	$385M	$273M
Current Ratio (TTM)	3.39x	10.45x
Quick Ratio (TTM)	3.11x	10.21x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.91	0.04
52W Performance	-7.2%	34.5%
YTD Performance	-24.8%	6.7%
% from 52W High	-36.1%	-15.4%
% from 52W Low	2.4%	38.6%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.20x
FCF Yield (TTM)	4.3%	-3.3%
Earnings Yield (TTM)	11.2%	-5.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	61.1	3,196.0
EV/GP/RG	0.09	N/A
Ticker research	View ACAD research	View IDYA research

Valuation

P/E Ratio

ACAD

8.99x

P/S Ratio

ACAD

2.97x

IDYA

14.66x

EV/FCF

IDYA

-27.76x

ACAD

20.62x

Growth & revenue

Revenue Growth TTM

IDYA

3244.7%

ACAD

48.3%

Forward Revenue Growth

IDYA

218.2%

ACAD

12.6%

Profitability & performance

Gross Margin

ACAD

91.1%

IDYA

0.0%

ROE

ACAD

32.4%

IDYA

-1647.0%

FCF Yield %

ACAD

4.3%

IDYA

-3.3%

52-Week Performance

IDYA

34.5%

ACAD

-7.2%

Detailed metrics comparison

ACAD

ACADIA Pharmaceuticals Inc

IDYA

IDEAYA Biosciences Inc

Market Cap

ACAD$3.39B

IDYA$3.43B

Enterprise Value

ACAD$3.00B

IDYA$3.16B

Price

ACAD$19.78

IDYA$36.11

P/E Ratio

ACAD8.99x

IDYAN/A

P/S Ratio

ACAD2.97x

IDYA14.66x

EV/Sales

ACAD2.64x

IDYA13.50x

EV/EBITDA

ACAD24.70x

IDYA0.00x

P/B Ratio

ACAD2.63x

IDYA3.01x

P/FCF Ratio

ACAD23.26x

IDYAN/A

EV/FCF

ACAD20.62x

IDYA-27.76x

PEG Ratio

ACAD0.13x

IDYAN/A

Forward P/E (NTM)

ACAD23.42x

IDYAN/A

Forward P/S (NTM)

ACAD2.37x

IDYA59.38x

Revenue (TTM)

ACAD$1.14B

IDYA$234M

Revenue Growth (YoY)

ACAD48.3%

IDYA3244.7%

Forward Rev Growth

ACAD12.6%

IDYA218.2%

Gross Margin (TTM)

ACAD91.1%

IDYA0.0%

Operating Margin (TTM)

ACAD7.6%

IDYA0.0%

EBITDA Margin (TTM)

ACAD8.6%

IDYA-91.5%

Net Margin (TTM)

ACAD33.4%

IDYA-74.8%

FCF Margin (TTM)

ACAD12.8%

IDYA-48.6%

Net Income (TTM)

ACAD$380M

IDYA$-175M

FCF (TTM)

ACAD$146M

IDYA$-114M

EPS (TTM)

ACAD$2.20

IDYA-$1.90

ROE (TTM)

ACAD32.4%

IDYA-1647.0%

ROA (TTM)

ACAD24.4%

IDYA-1511.0%

ROIC (TTM)

ACAD32.4%

IDYA-1647.0%

Cash

ACAD$385M

IDYA$273M

Debt

ACAD$0

IDYA$0

Net Cash/Debt

ACAD$385M

IDYA$273M

Current Ratio (TTM)

ACAD3.39x

IDYA10.45x

Quick Ratio (TTM)

ACAD3.11x

IDYA10.21x

Debt/Equity (TTM)

ACAD0.00x

IDYA0.00x

Debt/Assets (TTM)

ACAD0.0%

IDYA0.0%

Interest Coverage (TTM)

ACADN/A

IDYAN/A

Net Debt/EBITDA (TTM)

ACAD0.00x

IDYA0.00x

Beta

ACAD0.91

IDYA0.04

52W Performance

ACAD-7.2%

IDYA34.5%

YTD Performance

ACAD-24.8%

IDYA6.7%

% from 52W High

ACAD-36.1%

IDYA-15.4%

% from 52W Low

ACAD2.4%

IDYA38.6%

Asset Turnover (TTM)

ACAD0.73x

IDYA0.20x

FCF Yield (TTM)

ACAD4.3%

IDYA-3.3%

Earnings Yield (TTM)

ACAD11.2%

IDYA-5.1%

Dividend Yield (TTM)

ACADN/A

IDYAN/A

Rule of 40

ACAD61.1

IDYA3,196.0

EV/GP/RG

ACAD0.09

IDYAN/A

Ticker research

View ACAD research View IDYA research

Metric	ACAD ACADIA Pharmaceuticals Inc	IDYA IDEAYA Biosciences Inc
Market & Valuation
Market Cap	$3.39B	$3.43B
Enterprise Value	$3.00B	$3.16B
Price	$19.78	$36.11
P/E Ratio	8.99x	N/A
P/S Ratio	2.97x	14.66x
EV/Sales	2.64x	13.50x
EV/EBITDA	24.70x	0.00x
P/B Ratio	2.63x	3.01x
P/FCF Ratio	23.26x	N/A
EV/FCF	20.62x	-27.76x
PEG Ratio	0.13x	N/A
Forward P/E (NTM)	23.42x	N/A
Forward P/S (NTM)	2.37x	59.38x
Revenue & Growth
Revenue (TTM)	$1.14B	$234M
Revenue Growth (YoY)	48.3%	3244.7%
Forward Rev Growth	12.6%	218.2%
Profitability
Gross Margin (TTM)	91.1%	0.0%
Operating Margin (TTM)	7.6%	0.0%
EBITDA Margin (TTM)	8.6%	-91.5%
Net Margin (TTM)	33.4%	-74.8%
FCF Margin (TTM)	12.8%	-48.6%
Net Income (TTM)	$380M	$-175M
FCF (TTM)	$146M	$-114M
EPS (TTM)	$2.20	-$1.90
ROE (TTM)	32.4%	-1647.0%
ROA (TTM)	24.4%	-1511.0%
ROIC (TTM)	32.4%	-1647.0%
Financial Health
Cash	$385M	$273M
Debt	$0	$0
Net Cash/Debt	$385M	$273M
Current Ratio (TTM)	3.39x	10.45x
Quick Ratio (TTM)	3.11x	10.21x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.91	0.04
52W Performance	-7.2%	34.5%
YTD Performance	-24.8%	6.7%
% from 52W High	-36.1%	-15.4%
% from 52W Low	2.4%	38.6%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.20x
FCF Yield (TTM)	4.3%	-3.3%
Earnings Yield (TTM)	11.2%	-5.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	61.1	3,196.0
EV/GP/RG	0.09	N/A
Ticker research	View ACAD research	View IDYA research